Trastuzumab deruxtecan-related risk of ILD and pneumonitis

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2024年 / 2008卷 / 1期
关键词：
D O I：
10.1007/s40278-024-58906-x
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：12 / 12
相关论文
共 50 条
  • [1] Trastuzumab deruxtecan-related interstitial lung disease, pneumonitis
    Reactions Weekly, 2022, 1921 (1) : 12 - 12
  • [2] Trastuzumab Deruxtecan-Related Interstitial Lung Disease/Pneumonitis: Computed Tomography Imaging Patterns to Guide Diagnosis and Management
    Nishino, Mizuki
    Kusumoto, Masahiko
    Bankier, Alexander A.
    Kurihara, Yasuyuki
    Zhang, Lin
    Rasheed, Zeshaan
    Meinhardt, Gerold
    Arunachalam, Meena
    Taitt, Corina
    Wang, Qiang
    Powell, Charles A.
    JCO PRECISION ONCOLOGY, 2023, 7
  • [3] Management of trastuzumab deruxtecan-related nausea and vomiting in real-world practice
    Licata, L.
    Notini, G.
    Sica, L.
    Viale, G.
    Zambelli, S.
    Rognone, A.
    Aldrighetti, D.
    Piras, M.
    Nuccio, A.
    Zucchinelli, P.
    Bianchini, G.
    ANNALS OF ONCOLOGY, 2023, 34 : S1098 - S1098
  • [4] Management of Trastuzumab Deruxtecan-related nausea and vomiting in real-world practice
    Notini, Giulia
    Naldini, Matteo Maria
    Sica, Lorenzo
    Viale, Giulia
    Rognone, Alessia
    Zambelli, Stefania
    Zucchinelli, Patrizia
    Piras, Marta
    Bosi, Carlo
    Mariani, Marco
    Aldrighetti, Daniela
    Bianchini, Giampaolo
    Licata, Luca
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [5] Trastuzumab deruxtecan: risk of interstitial lung disease/pneumonitis
    Reactions Weekly, 2022, 1915 (1) : 10 - 10
  • [6] A Systematic Review of Mechanisms, Incidence, and Management of Trastuzumab Deruxtecan Induced ILD/Pneumonitis in Solid Tumors
    Liao, Dehua
    Zhang, Jiwen
    Yan, Ting
    Chen, Yun
    Fu, Yilan
    Xie, Ning
    Long, Minghui
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2025, 19 : 1655 - 1668
  • [7] INCIDENCE AND RISK FACTORS FOR PNEUMONITIS DUE TO TRASTUZUMAB DERUXTECAN IN FEMALES WITH BREAST CANCER
    Azhar, Maria
    Soto, Felipe
    Vazquez-Gonzalez, Norma Alicia
    Su, Amber
    Mouabbi, Jason
    Faiz, Saadia A.
    Sheshadri, Ajay
    CHEST, 2024, 166 (04) : 3513A - 3514A
  • [8] Evaluating risk factors for Trastuzumab-Deruxtecan Pneumonitis in patients with metastatic breast cancer
    Henricks, Jonathan
    Haddad, Tyler
    Ahmed, Omair
    Schoenhals, Jonathan
    Kumar, Pavnesh
    Wilson, Ryan
    Ma, Jianing
    Wang, Jing Gennie
    Wert, Michael
    Esguerra, Vincent
    Bentley, Ian
    Johnson, Kai
    Stover, Daniel
    Jhawar, Sachin R.
    Gatti-Mays, Margaret
    Ho, Kevin
    BREAST CANCER RESEARCH, 2025, 27 (01)
  • [9] Evaluation of Pre-treatment Risk Factors for Development of Trastuzumab Deruxtecan Associated Pneumonitis
    Ahmed, O.
    Henricks, J.
    Haddad, T.
    Ma, J.
    Esguerra, V. G.
    Wang, J.
    Wert, M. J.
    Gatti-Mays, M.
    Ho, K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [10] Pooled analysis of drug-related interstitial lung disease and/or pneumonitis in nine trastuzumab deruxtecan monotherapy studies
    Powell, C. A.
    Modi, S.
    Iwata, H.
    Takahashi, S.
    Smit, E. F.
    Siena, S.
    Chang, D-Y
    Macpherson, E.
    Qin, A.
    Singh, J.
    Taitt, C.
    Shire, N.
    Camidge, D. Ross
    ESMO OPEN, 2022, 7 (04)
12345